Modulation by serum glucose levels on morphine-induced antinociceptive effect in C57BL/KsJ-db/db mice.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Life Science

• Publication date

  1997-11-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0024-3205(97)01041-2PMID 9444971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for the modulation of spontaneous locomotor activity by higher serum glucose levels and/or spleen-derived factor(s) in diabetic mice.

  1997cited by this paper
• Role of spleen or spleen products in the reduced locomotor-enhancing effect of morphine in diabetic mice.

  1996cited by this paper
• Antinociceptive effects of the selective non-peptidic δ-opioid receptor agonist TAN-67 in diabetic mice

  1995cited by this paper
• Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.

  1995cited by this paper
• Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice.

  1995cited by this paper
• Evidence for differential modulation of mu-opioid receptor-mediated antinociceptive and antitussive activities by spleen-derived factor(s) from diabetic mice.

  1994cited by this paper
• Effects of diabetes on spontaneous locomotor activity in mice.

  1994cited by this paper
• Evidence for differential modulation of μ-opioid receptor-mediated antinociceptive and antitussive activities by spleen-derived factor(s) from diabetic mice

  1994cited by this paper
• Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors.

  1994cited by this paper
• Serum glucose level-dependent and independent modulation of mu-opioid agonist-mediated analgesia in diabetic mice.

  1993cited by this paper
• Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.

  1992cited by this paper
• Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice.

  1992cited by this paper
• Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.

  1991cited by this paper
• Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine.

  1981cited by this paper
• Studies with the mutation, diabetes, in the mouse

  1967cited by this paper
• An o-toluidine method for body-fluid glucose determination.

  1962cited by this paper

• A Systematic Review on Neuropathy

  2016cites this paper
• Comparing cardiovascular factors in opium abusers and non-users candidate for coronary artery bypass graft surgery

  2015cites this paper
• An Investigation into the Role of Insulin in Pain Threshold.

  2014cites this paper
• POSSIBLE MECHANISM OF HYPERGLYCEMIA INDUCED DECREASE IN ANTINOCICEPTIVE EFFECT OF ANALGESICS IN RATS

  2010cites this paper
• Murine models of human neuropathic pain.

  2010cites this paper
• Beneficial Effect of Cyclosporine in Experimental Diabetes Induced Neuropathic Pain in Rats

  2010cites this paper
• Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.

  2008cites this paper
• Opium can differently alter blood glucose, sodium and potassium in male and female rats.

  2008cites this paper
• [Animal models of neuropathic pain].

  2006cites this paper
• Effects of opium addiction on some serum factors in addicts with non‐insulin‐dependent diabetes mellitus

  2004cites this paper
• Possible Role of the Phosphoinositide Pathway for Signal Transduction in Changes in the Sensitivity of δ-Opiate Receptors during Diabetes Mellitus

  2004cites this paper
• The analgesic effect of morphine on postoperative pain in diabetic patients

  2004influential citation
• Animal and cellular models of chronic pain.

  2003cites this paper
• Therapeutic potential of PKC inhibitors in painful diabetic neuropathy.

  2002cites this paper
• Role of L-type Ca2+ channels in attenuated morphine antinociception in streptozotocin-diabetic rats.

  2002cites this paper
• Therapeutic potential of PKC inhibitors in painful diabetic neuropathy

  2001cites this paper
• ANTINOCICEPTIVE EFFECT OF BACLOFEN IN ALLOXAN-INDUCED DIABETIC MICE

  2001cites this paper
• Decreased opioid-induced antinociception but unaltered G-protein activation in the genetic-diabetic NOD mouse.

  2000cites this paper
• Intraventricular insulin reduces the antinociceptive effect of [D-Ala2, NMePhe4, Gly-ol5]enkephalin in mice.

  1998cites this paper